Similar in vivo results were observed in NSCLC; tumour growth was inhibited when FSTL1 was overexpressed in the CL1-5 cell line and promoted when FSTL1 expression was downregulated in the CL1-0 cell line [58]. The gene discussed is FSTL1; the disease is non-small cell lung carcinoma.